12 November 2024 in Journal of Hepatology
Immune responses by CD8 T cells are essential for control of HBV replication. Although selection of escape mutations in CD8 T-cell epitopes has previously been described in HBV infection, its overall influence on HBV sequence diversity and correlation with markers of HBV replication remain unclear. Whole-genome sequencing was applied to HBV isolates from 532 patients with chronic HBV infection and high-resolution HLA class I genotyping. Using a Bayesian model (HAMdetector) for identification of HLA-associated mutational states (HAMs), the frequency and location of residues under CD8 T-cell selection pressure were determined and the levels of adaptation of individual isolates were quantified. Using previously published thresholds for the identification of HAMs, a total of 295 residues showed evidence of CD8 T-cell escape, the majority of which were located in previously unidentified epitopes. Interestingly, HAMs were highly enriched in the HBV core protein compared to all other proteins. When individual HBV isolates were compared, different levels of adaptation to HLA class I immune pressure were noted. The level of adaptation increased with patient age and correlated with markers of replication, with low levels of adaptation in HBeAg-positive infection. Furthermore, the levels of adaptation negatively correlated with HBV viral load and HBsAg levels, consistent with high levels of HLA class I-associated selection pressure in patients with low replication levels. HBV sequence diversity is shaped by HLA class I-associated selection pressure with the HBV core protein being a predominant target of selection. Importantly, different levels of adaptation to immune pressure were observed between HBV infection stages, which need to be considered in the context of T-cell-based therapies. The immune response mediated by CD8 T cells plays a critical role in controlling HBV infection and shows promise for therapeutic strategies aimed at achieving a functional cure. This study demonstrates that mutational escape within CD8 T-cell epitopes is common in HBV and represents a key factor in the failure of immune control. Notably, the HBV core protein emerges as the primary target of CD8 T-cell selection pressure. Additionally, the observed correlation between HBV adaptation levels and viral replication markers indicates that CD8 T-cell immunity may influence transitions between phases of chronic HBV infection.
27 June 2025 in PLOS Genetics
A hallmark of the highly conserved CYP4B1 enzyme in mammals is the capability to bioactivate both xenobiotic and endobiotic substrates. However, due to a single amino acid change (p.P427S) within the evolutionary conserved meander region no catalytic activity of the native human CYP4B1 has been identified so far. To identify at which point in human evolution the loss of CYP4B1 activity had occurred, we evaluated the activities of CYP4B1 orthologs from 14 primate genera against 4-ipomeanol and perilla ketone in human liver cells. The activity of recombinant CYP4B1 proteins isolated from E. coli was also tested against 4-ipomeanol and lauric acid. Surprisingly, CYP4B1 already became catalytically inactive at the split between apes and monkeys; all tested CYP4B1 orthologs from monkeys were able to bioactivate both protoxins and to hydroxylate lauric acid. Amino acid analysis of the CYP4B1 orthologs revealed four additional evolutionary changes, each affecting the function of ape and human enzymes: p.V71G specific for Denisovans, p.R106C, p.R244H, and an exon deletion found only in the gorilla CYP4B1. Systematic functional analyses proved the negative impact of the genetic changes on CYP4B1 activity and showed that reversion of the mutations restored enzyme activity. The occurrence of five independent inactivating genetic changes in the same gene of closely related species is a clear indication of the importance of inactivating CYP4B1 in apes and humans. Elucidating the evolutionary trigger(s) for CYP4B1 inactivation in our ancestors will ultimately improve our understanding of primate evolution.
1 January 2020 in Cancer Informatics
Reporting of a single nucleotide variant (SNV) follows the Sequence Variant Nomenclature ( http://varnomen.hgvs.org/ ), using an unambiguous numbering scheme specific for coding and noncoding DNA. However, the corresponding sequence neighborhood of a given SNV, which is required to assess its impact on splicing regulation, is not easily accessible from this nomenclature. Providing fast and easy access to this neighborhood just from a given SNV reference, the novel tool VarCon combines information of the Ensembl human reference genome and the corresponding transcript table for accurate retrieval. VarCon also displays splice site scores (HBond and MaxEnt scores) and HEXplorer profiles of an SNV neighborhood, reflecting position-dependent splice enhancing and silencing properties.
24 April 2026 in JHEP Reports
Function and quantity of CD8+ T cell responses is superior in acute versus chronic HBV infection. Whether different HBV-derived epitopes are targeted in these distinct courses of HBV infection remains, however, incompletely understood. PBMC from 56 patients with chronic HBV infection genotype D and 32 patients with acute or resolved HBV infection were screened for responses to overlapping peptides (18mers) covering the full HBV genotype D proteome with subsequent comprehensive experimental fine-mapping of the minimal optimal epitopes. Patients with acute HBV infection showed a broad HBV-specific CD8+ T cell epitope repertoire. After spontaneous resolution, the strength of HBV-specific CD8 T cell responses decreased, while the broad epitope landscape was preserved. In chronic HBV infection, the specificity of HBV-specific CD8+ T cell responses to HBV antigens was shifted, with a lack of functional HBsAg-specific CD8+ T cell responses (p=0.0007), as recently described. Interestingly, in patients with chronic HBV infection significantly more HLA-B- than HLA-A-restricted HBV-specific CD8+ T cell responses were detectable (33 and 19 responses, respectively), while this distribution was balanced in acute/resolved HBV infection (16 and 27 responses, respectively; p=0.0364). Most (79.6%) of the detected responses showed conserved autologous viral sequences. This observation was confirmed in a broader sequence dataset with no evidence for HLA-B driven CD8+ T cell selection pressure. In contrast to acute/resolved infection, conserved HLA-B-restricted epitopes are dominant in chronic HBV infection, making them interesting candidates for immunotherapeutic approaches towards functional cure of chronic HBV infection. To date, there is no treatment to achieve functional cure of chronic HBV infection. Immunotherapy boosting dysfunctional HBV-specific CD8+ T cells is an interesting approach, but relies on selection of optimal target epitopes. Using an unbiased approach, we found that the HBV-specific CD8+ T cell epitope repertoire in chronic HBV infection is not well covered by previously described epitopes. We characterized 28 novel, primarily HLA-B-restricted epitopes that are dominantly targeted in chronic HBV infection and might be used as a "toolbox" for immunological studies and the development of immunotherapeutic approaches.
29 March 2025 in NAR Genomics and Bioinformatics
This work presents a comprehensive investigation of sequence variations at human 5′ splice sites (5′ss), exploring their impact on 5′ss strength and predicted splicing regulatory protein (SRP) binding. Leveraging 44 high-quality genomes, with fully haplotyped assemblies, we were able to fully assess homozygous and heterozygous sequence variations around and within 5′ss. Variations showed differing tolerance levels in protein-coding and non-coding transcripts. Around half of 5′ss variations did not alter 5′ss strength (measured by the HBond score, that estimates binding of the 11 nucleotides at the free U1 spliceosomal RNA 5′ end). Heterozygous variations resulted in stronger 5′ss strength reductions and less compensatory effects of multiple sequence variations at the same 5′ss, compared to homozygous variations. Additionally, we observed a slight balance between changes in 5′ss strength and predicted SRP binding. Strong 5′ss (HBond score >18.8) showed strength variations in both directions, as theoretically expected for random distributions, whereas weaker 5′ss consistently showed lower strength reductions than expected or achievable. Variations at 5′ss of essential genes were less frequent than in other genes and showed a higher amount of variations that did not alter 5′ss strength. Acceptable changes in predicted SRP binding sites were highly dependent on their respective 5′ss strength.